Ocular abnormalities in the mucopolysaccharidoses after bone marrow transplantation. Longer follow-up

Ophthalmology

Volumn 105, Issue 6, 1998, Pages 1099-1105

  Gullingsrud, Eugene O ^a   Krivit, William ^b   Summers, C Gail ^a,b,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE;

ARTICLE; BLINDNESS; BONE MARROW TRANSPLANTATION; CATARACT; CHILD; CLINICAL ARTICLE; ELECTRORETINOGRAPHY; EYE DISEASE; GLAUCOMA; HUMAN; HUMAN TISSUE; INFANT; INTRAOCULAR HYPERTENSION; KERATOCONJUNCTIVITIS; MUCOPOLYSACCHARIDOSIS; NYSTAGMUS; OPTIC NERVE ATROPHY; PAPILLEDEMA; PRIORITY JOURNAL; STRABISMUS;

EID: 0031834971     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(98)96014-6     Document Type: Article

References (54)

1. Hobbs JR, Barrett AJ, Chambers D, et al. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone marrow transplantation. Lancet 1981;2:709-12.
2. Krivit W. Correction of inborn errors of metabolism by bone marrow transplant. Basic Life Sciences 1983;25:63-76.
3. Krivit W, Pierpont ME, Ayaz K, et al. Bone marrow transplantation in the Maroteaux-Lamy syndrome. New Engl J Med 1984;311:1606-11.
4. Whitley CB, Ramsay NK, Kersey JH, et al. Bone marrow transplantation for Hurler syndrome: assessment of metabolic correction. Birth Defects 1986;22:7-24.
5. Hugh-Jones K. Psychomotor development of children with mucopolysaccharidosis type 1H following bone marrow transplantation. Birth Defects 1986;22:25-9.
6. Malone BN, Whitley CB, Duvall AJ, et al. Resolution of obstructive sleep apnea in Hurler syndrome after bone marrow transplantation. Int J Pediatr Otorhinolaryngol 1988; 15:23-31.
7. Summers CG, Purple RL, Krivit W, et al. Ocular changes in the Mucopolysaccharidoses after bone marrow transplantation - a preliminary report. Ophthalmology 1989; 96:977-85.
8. Christiansen SP, Smith TJ, Henslee-Downey PJ. Normal intraocular pressure after a bone marrow transplant in glaucoma associated with mucopolysaccharidosis type IH. Am J Ophthalmol 1990;109:230-1.
9. Belani KG, Krivit W, Carpenter BL, et al. Children with mucopolysaccharidosis: perioperative care, morbidity, mortality and new findings. J Pediatric Surg 1993;28:403-10.
10. Whitley CB, Belani KG, Chang PN, et al. Long term outcome of Hurler syndrome following bone marrow transplantation. Am J Med Gen 1993;46:209-18.
11. Shapiro EG, Lockman LA, Balthazor M, Krivit W. Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J Inherit Metab Dis 1995;18:413-29.
12. Hoogerbrugge PN, Brouwer OF, Bordigoni P, et al. Allogenic bone marrow transplantation for lysosomal storage diseases. Lancet 995;45:1398-402.
13. Gatzoulis MA, A Vellodi, Redington AN. Cardiac involvement in mucopolysaccharidoses: effects of allogenic bone marrow transplantation. Arch Dis Child 1995;73:259-60.
14. Franklin RM, Kenyon KR, Tutschka PJ, et al. Ocular manifestations of graft vs. host disease. Ophthalmology 1983;90:4-13.
15. Vogler WR, Winton EF, Heffner LT, et al. Ophthalmological and other toxicities related to cytosine arabinoside and total body irradiation as preparative regimen for bone marrow transplantation. Bone Marrow Transplant 1990;6:405-9.
16. Arocker-Mettinger E, Skorpik F, Grabner G, et al. Manifestations of graft versus host disease following allogenic bone marrow transplantation. Eur J Ophthalmol 1991; 1:28-32.
17. Hirst LW, Jabs DA, Tutschka PJ, et al. The eye in bone marrow transplantation I. Arch Ophthalmol 1983;101:580-4.
18. Jabs DA, Hirst LW, Green R, et al. The eye in bone marrow transplantation II. Arch Ophthalmol 1983;10:585-90.
19. Jabs DA, Wingard J, Green WR, et al. The eye in bone marrow transplantation III. Arch Ophthalmol 1989;107: 1343-8.
20. Coskuncan NM, Jabs DA, Dunn JP, et al. The eye in bone marrow transplantation IV. Arch Opthalmol 1994;112: 372-9.
21. Lappi M, Rajantie J, Uusito RJ. Irradiation cataract in children after bone marrow transplantation. Grafes Arch Clin Exp Ophthalmol 1990;228:218-21.
22. Calissendorff B, Bolme P, el Azazi M. The development of cataract in children as a late side effect of bone marrow transplantation. Bone Marrow Transplant 1991;7:427-9.
23. Calissendorff BM, Bolme P. Cataract development and outcome of surgery in bone marrow transplanted children. Br J Ophthalmol 1993;77:36-8.
24. Tichelli A, Gratwohl A, Egger T, et al. Cataract formation after bone marrow transplantation. Ann Intern Med 1993;119:1175-80.
25. Calissendorff BM, B Lonnqvist, el Azazi M. Cataract development in adult bone marrow transplant recipients. Acta Ophthalmol 1995;73:152-4.
26. Benyunes MC, Sullivan KM, Deeg HJ, et al. Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation. Int J Radiat Oncol Biol Phys 1995;32:661-70.
27. Belkacemi Y, Ozsahin M, Pene F. Cataractogenesis after total body irradiation. Int J Radiat Oncol Biol Phys 1996;35:53-60.
28. Pauleikhoff D, Messmer E, Beelen DW, et al. Bone marrow transplantation and toxoplasmic retinochoroiditis. Graefes Arch Clin Exp Ophthalmol 1987;225:239-43.
29. Bernauer W, Gratwohl A, Keller A, et al. Microvasculopathy in the ocular fundus after bone marrow transplantation. Ann Intern Med 1991;115:925-30.
30. Lopez PF, Sternberg P, Dabbs CK, et al. Bone marrow transplant retinopathy. Am J Ophthalmol 1991;112:635-46.
31. Bernauer W, Gratwohl A. Comment. Am J Ophthalmol 1992;113:604-5.
32. Dunn JP, Jabs DA. Letters. Ann Intern Med 1992;116:956-7.
33. Pettitt AR, Neoh C, Wong SDH, Clark RE. Vogt-Koyanagi-Harada syndrome complicating allogenic bone marrow transplantation. Bone Marrow Transplant 1994;13: 225-7.
34. Webster AR, Anderson JR, Richards EM, Moore AT. Ischaemic retinopathy occurring in patients receiving bone marrow allografts and campath-1G: a clinicopathological study. Br J Ophthalmol 1995;79:687-91.
35. Khawly JA, Rubin P, Petros W, et al. Retinopathy and optic neuropathy in bone marrow transplantation for breast cancer. Ophthalmology 1996;103:87-95.
36. Avery R, Jabs DA, Wingard JR, et al. Optic disc edema after bone marrow transplantation - possible role of cyclosporin toxicity. Ophthalmology 1991;98:1294-301.
37. Hoogerbrugge PM, Brouwer OF, Fischer A. Bone marrow transplantation for metabolic diseases with severe neurological symptoms. Bone Marrow Transplant 1991;7:71.
38. Field RE, Buchanan JAF, Copplemans MGJ, Aichroth PM. Bone marrow transplantation in Hurler's syndrome - effect on skeletal development. J Bone Joint Surg 1994;76:975-81.
39. International Standardization Committee. Standard for clinical electroretinography. Arch Ophthalmol 1989;107:816-9.
40. Mayer DL, Beiser AS, Warner AF, et al. Monocular acuity norms for the Teller acuity cards between ages one month and four years. Invest Ophthalmol Vis Sci 1995;36:671-85.
41. Salomão SR, Ventura DF. Large sample population age norms for visual acuities obtained with Vistech-Teller acuity cards. Invest Ophthalmol Vis Sci 1995;36:657-70.
42. Francois J. Ocular manifestations in the mucopolysaccharidoses. Ophthalmologica 1974;169:345-69.
43. Krivit W, Lockman LA, Watkins PA, Hirsch J. The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome. J Inherit Metab Dis 1995;18:398-412.
44. Klein KA, Krivit W, Whitley CB, et al. Poor cognitive outcome of eleven children with Sanfilippo syndrome after bone marrow transplantation and successful engraftment. Bone Marrow Transplant 1995;15:S176-81.
45. Vellodi A, Young EP, Cooper A, et al. Bone marrow transplantation for mucopolysaccharidosis type 1: experience of two British centres. Arch Dis Child 1997;76:92-9.
46. Schwartz MF, Werblin TP, Green WR. Occurrence of mucopolysaccharide in corneal grafts in the Maroteaux-Lamy syndrome. Cornea 1985/1986;4:58-66.
47. Deeg HJ, Flournoy N, Sullivan KM, Sheehan K. Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. Int J Radiat Oncol Biol Phys 1984;10:957-64.
48. Urban RC, Collier E. Corticosteroid-induced cataracts. Surv Ophthalmol 1986;31:102-10.
49. Akman N, Avanoglu Y, Soysal T. Cataract after busulfan therapy. Acta Haematol 1986;76:236.
50. Caruso RC, Kaiser-Kupfer MI, Muenzer J, et al. Electroretinographic findings in the mucopolysaccharidoses. Ophthalmology 1986;93:1612-6.
51. Downie C, Hugh-Jones K, Hobbs JR. Up to fourteen years after bone marrow transplantation for Hurler's syndrome. In: Steward CC, Hobbs JR, eds. Correction of Genetic Diseases by Transplantation, III. London: COGENT, 1995;16-24.
52. Hopwood JJ, Vellodi A, Scott HS, et al. Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype. J Inherit Metab Dis 1993;16:1024-33.
53. Krivit W, Shapiro EG, Balthazor M, et al. Hurler syndrome: outcomes and planning following bone marrow transplantation. In: Steward CG, Hobbs JR, eds. Correction of Genetic Diseases by Transplantation, III. London: COGENT, 1995;25-40.
54. Peters C, Balthazor M, Shapiro EG, et al. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 1996;87:4894-902.